Market Research Logo

Gastrointestinal Drugs Market Global Report 2017 Including: Antacids, Antiulcerants, Vitamin And Minerals, Antiobesity Drugs, Antiemetics And Antinauseants, AntidiarrhoealsCovering: AbbVie, Johnson & Johnson, Takeda Pharmaceticals, Allergan, and UCB

Gastrointestinal Drugs Market Global Report 2017 Including: Antacids, Antiulcerants, Vitamin And Minerals, Antiobesity Drugs, Antiemetics And Antinauseants, AntidiarrhoealsCovering: AbbVie, Johnson & Johnson, Takeda Pharmaceticals, Allergan, and UCB

The Gastrointestinal Drugs Market Global Report provides strategists, marketers and senior management with the critical information they need to assess the global gastrointestinal drugs sector.

Reasons to Purchase

  • Outperform competitors using accurate up to date demand-side dynamics information.
  • Identify growth segments for investment.
  • Facilitate decision making on the basis of historic and forecast data and the drivers and restraints on the market.
  • Create regional and country strategies on the basis of local data and analysis.
  • Stay abreast of the latest customer and market research findings
  • Benchmark performance against key competitors.
  • Develop strategies based on likely future developments.
  • Utilize the relationships between key data sets for superior strategizing.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Gain a global perspective on the development of the market.
  • Report will be updated with the latest data and delivered to you within 3-5 working days of order.
Description:

Where is the largest and fastest growing market for the Gastrointestinal Drugs? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The gastrointestinal drugs market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography. It places the market within the context of the wider pharmaceutical drugs market, and compares it with other markets.
  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market and forecasting the future. Drivers and restraints looks at the external factors supporting and controlling the growth of the market.
  • Market segmentations break down market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers all the regions, key developed countries and major emerging markets. It draws comparisons with country populations and economies to understand the importance of the market by country and how this is changing.
  • Competitive landscape gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section highlights the likely future developments in the market and suggests approaches companies can take to exploit this.
  • The gastrointestinal drugs market section of the report gives context. It compares the gastrointestinal drugs market with other segments of the pharmaceutical drugs market by size and growth, historic and forecast. It analyses Expenditure Per Capita, The Gastrointestinal Drugs Indicators Comparison.
  • The industry metrics section looks at critical drivers including patient numbers (epidemiology) hospital beds and specialist physicians while the macro-economic section looks at the market in relation to the overall economy.
Scope

Markets Covered: Antacids, Antiulcerants, Vitamin And Minerals, Antiobesity Drugs, Antiemetics And Antinauseants, Antidiarrhoeals

Companies Mentioned: AbbVie, Johnson & Johnson, Takeda Pharmaceticals, Allergan, and UCB

Countries: Brazil, China, France, Germany, India, Italy, Japan, Spain, Russia, UK, USA and Australia.

Regions: Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East And Africa

Time series: Five years historic and forecast.

Data: Ratios of market size and growth to related markets, GDP, Expenditure Per Capita, The Gastrointestinal Drugs Indicators Comparison.

Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.

Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.

Please Note: Report will be updated with the latest data and delivered to you within 3-5 working days of order.


1. Gastrointestinal Drugs Market Characteristics
2. Gastrointestinal Drugs Market Size And Growth
2.1. Historic Market Growth
2.1.1. Drivers Of The Market
2.1.2. Restraints On The Market
2.2. Forecast Market Growth
2.2.1. Drivers Of The Market
2.2.2. Restraints On The Market
3. Pestle Analysis
3.1. Political
3.2. Economic
3.3. Social
3.4. Technological
3.5. Legal
3.6. Environmental
4. Gastrointestinal Drugs Market Customer Information
5. Gastrointestinal Drugs Market Segmentation
5.1. Global Gastrointestinal Drugs Market, 2016, By Segment
Antacids
Antiulcerants
Vitamin And Minerals
Antiobesity Drugs
Antiemetics And Antinauseants
Antidiarrhoeals
5.2. Global Gastrointestinal Drugs Market, 2012 - 2020, Historic And Forecast, By Segment
5.3 Global Gastrointestinal Drugs Market Trends And Strategies
6. Gastrointestinal Drugs Market Regional And Country Analysis
6.1. Global Gastrointestinal Drugs Market, 2016, By Region
6.2. Global Gastrointestinal Drugs Market, 2012 - 2020, Historic And Forecast, By Region
6.3. Gastrointestinal Drugs Market, 2016, By Country
6.4. Gastrointestinal Drugs Market, 2012 - 2020, Historic And Forecast, By Country
6.5. Global Pharmaceutical Market Segments, 2016, By Region
6.6. Global Pharmaceutical Drugs Market Segments, 2016, By Region
6.7. Global Pharmaceutical Market Segments, 2016, By Country
6.8. Global Pharmaceutical Drugs Market Segments, 2016, By Country
7. Global Gastrointestinal Drugs Market Comparison With Macro Economic Factors
7.1. Gastrointestinal Drugs Market Size, Percentage Of GDP, Global
7.2. Per Capita Average Gastrointestinal Drugs Expenditure, Global
8. Gastrointestinal Drugs Market Comparison With Macro Economic Factors Across Countries
8.1. Gastrointestinal Drugs Market Size, Percentage Of GDP, By Country
8.2. Per Capita Average Gastrointestinal Drugs Expenditure, By Country
9. Gastrointestinal Drugs Market Comparison With Industry Metrics
9.1. Global Number Of Pharmacists, 2016, By Country
9.2. Global Gastrointestinal Drugs Market Revenue Versus Number Of Pharmacists, 2016, By Country
9.3. Global Number Of Pharma Enterprises, 2016, By Country
9.4. Global Gastrointestinal Drugs Market Revenue Versus Number Of Pharma Enterprises, 2016, By Country
9.5. Global Average Spending On R&D/Product Development, 2016, By Country
9.6. Global Gastrointestinal Drugs Market Revenue Versus Average Spending On R&D/Product Development, 2016, By Country
9.7. Global Generic & Branded Sales Proportion By Country (Value), 2016, By Country
9.8. Global Gastrointestinal Drugs Market Revenue Versus Generic & Branded Sales Proportion By Country (Value), 2016, By Country
9.9. Prevalent Cases Of Peptic Ulcer, 2014, By Country
9.10. Global Number Of General Practitioners 2016, By Country
9.11. Global Gastrointestinal Drugs Market Revenue Versus Number Of General Practitioners, 2016, By Country
10. Asia-Pacific Gastrointestinal Drugs Market
10.1.1. Asia-Pacific Gastrointestinal Drugs Market Overview
10.1.2. Asia-Pacific Gastrointestinal Drugs Historic Market, 2012 - 2016
10.1.3. Asia-Pacific Gastrointestinal Drugs Forecast Market, 2016 - 2020
10.1.4. Asia-Pacific Gastrointestinal Drugs Market, 2016, By Segment
Antacids
Antiulcerants
Vitamin And Minerals
Antiobesity Drugs
Antiemetics And Antinauseants
Antidiarrhoeals
10.2. Asia-Pacific Gastrointestinal Drugs Market: Country Analysis
10.3. China Gastrointestinal Drugs Market
10.3.1. China Gastrointestinal Drugs Market Overview
10.3.2. China Gastrointestinal Drugs Historic Market, 2012 - 2016
10.3.3. China Gastrointestinal Drugs Forecast Market, 2016 - 2020
10.3.4. China Gastrointestinal Drugs Market, 2016, By Segment
Antacids
Antiulcerants
Vitamin And Minerals
Antiobesity Drugs
Antiemetics And Antinauseants
Antidiarrhoeals
10.3.5. China Gastrointestinal Drugs Percentage Of GDP, 2012 - 2020
10.3.6. China Per Capita Average Gastrointestinal Drugs Expenditure, 2012 - 2020
10.4. India Gastrointestinal Drugs Market
10.4.1. India Gastrointestinal Drugs Market Overview
10.4.2. India Gastrointestinal Drugs Historic Market, 2012 - 2016
10.4.3. India Gastrointestinal Drugs Forecast Market, 2016 - 2020
10.4.4. India Gastrointestinal Drugs Market, 2016, By Segment
Antacids
Antiulcerants
Vitamin And Minerals
Antiobesity Drugs
Antiemetics And Antinauseants
Antidiarrhoeals
10.4.5. India Gastrointestinal Drugs Percentage Of GDP, 2012 - 2020
10.4.6. India Per Capita Average Gastrointestinal Drugs Expenditure, 2012 - 2020
10.5. Japan Gastrointestinal Drugs Market
10.5.1. Japan Gastrointestinal Drugs Market Overview
10.5.2. Japan Gastrointestinal Drugs Historic Market, 2012 - 2016
10.5.3. Japan Gastrointestinal Drugs Forecast Market, 2016 - 2020
10.5.4. Japan Gastrointestinal Drugs Market, 2016, By Segment
Antacids
Antiulcerants
Vitamin And Minerals
Antiobesity Drugs
Antiemetics And Antinauseants
Antidiarrhoeals
10.5.5. Japan Gastrointestinal Drugs Percentage Of GDP, 2012 - 2020
10.5.6. Japan Per Capita Average Gastrointestinal Drugs Expenditure, 2012 - 2020
10.6. Australia Gastrointestinal Drugs Market
10.6.1. Australia Gastrointestinal Drugs Historic Market, 2012 - 2016
10.6.2. Australia Gastrointestinal Drugs Forecast Market, 2016 - 2020
10.6.3. Australia Gastrointestinal Drugs Market, 2016, By Segment
Antacids
Antiulcerants
Vitamin And Minerals
Antiobesity Drugs
Antiemetics And Antinauseants
Antidiarrhoeals
10.6.4. Australia Gastrointestinal Drugs Percentage Of GDP, 2012 - 2020
10.6.5. Australia Per Capita Average Gastrointestinal Drugs Expenditure, 2012 - 2020
11. Western Europe Gastrointestinal Drugs Market
11.1.1. Western Europe Gastrointestinal Drugs Market Overview
11.1.2. Western Europe Gastrointestinal Drugs Historic Market, 2012 - 2016
11.1.3. Western Europe Gastrointestinal Drugs Forecast Market, 2016 - 2020
11.1.4. Western Europe Gastrointestinal Drugs Market, 2016, By Segment
Antacids
Antiulcerants
Vitamin And Minerals
Antiobesity Drugs
Antiemetics And Antinauseants
Antidiarrhoeals
11.2. Western Europe Gastrointestinal Drugs Market: Country Analysis
11.3. UK Gastrointestinal Drugs Market
11.3.1. UK Gastrointestinal Drugs Market Overview
11.3.2. UK Gastrointestinal Drugs Historic Market, 2012 - 2016
11.3.3. UK Gastrointestinal Drugs Forecast Market, 2016 - 2020
11.3.4. UK Gastrointestinal Drugs Market, 2016, By Segment
Antacids
Antiulcerants
Vitamin And Minerals
Antiobesity Drugs
Antiemetics And Antinauseants
Antidiarrhoeals
11.3.5. UK Gastrointestinal Drugs Percentage Of GDP, 2012 - 2020
11.3.6. UK Per Capita Average Gastrointestinal Drugs Expenditure, 2012 - 2020
11.4. Germany Gastrointestinal Drugs Market
11.4.1. Germany Gastrointestinal Drugs Historic Market, 2012 - 2016
11.4.2. Germany Gastrointestinal Drugs Forecast Market, 2016 - 2020
11.4.3. Germany Gastrointestinal Drugs Market, 2016, By Segment
Antacids
Antiulcerants
Vitamin And Minerals
Antiobesity Drugs
Antiemetics And Antinauseants
Antidiarrhoeals
11.4.4 Germany Gastrointestinal Drugs Percentage Of GDP, 2012 - 2020
11.4.5 Germany Per Capita Average Gastrointestinal Drugs Expenditure, 2012 - 2020
11.5 France Gastrointestinal Drugs Market
11.5.1 France Gastrointestinal Drugs Historic Market, 2012 - 2016
11.5.2 France Gastrointestinal Drugs Forecast Market, 2016 - 2020
11.5.3 France Gastrointestinal Drugs Market, 2016, By Segment
Antacids
Antiulcerants
Vitamin And Minerals
Antiobesity Drugs
Antiemetics And Antinauseants
Antidiarrhoeals
11.5.4 France Gastrointestinal Drugs Percentage Of GDP, 2012 - 2020
11.5.5 France Per Capita Average Gastrointestinal Drugs Expenditure, 2012 - 2020
11.6. Italy Gastrointestinal Drugs Market
11.6.1. Italy Gastrointestinal Drugs Historic Market, 2012 - 2016
11.6.2. Italy Gastrointestinal Drugs Forecast Market, 2016 - 2020
11.6.3. Italy Gastrointestinal Drugs Market, 2016, By Segment
Antacids
Antiulcerants
Vitamin And Minerals
Antiobesity Drugs
Antiemetics And Antinauseants
Antidiarrhoeals
11.6.4. Italy Gastrointestinal Drugs Percentage Of GDP, 2012 - 2020
11.6.5. Italy Per Capita Average Gastrointestinal Drugs Expenditure, 2012 - 2020
11.7. Spain Gastrointestinal Drugs Market
11.7.1. Spain Gastrointestinal Drugs Historic Market, 2012 - 2016
11.7.2. Spain Gastrointestinal Drugs Forecast Market, 2016 - 2020
11.7.3. Spain Gastrointestinal Drugs Market, 2016, By Segment
Antacids
Antiulcerants
Vitamin And Minerals
Antiobesity Drugs
Antiemetics And Antinauseants
Antidiarrhoeals
11.7.4. Spain Gastrointestinal Drugs Percentage Of GDP, 2012 - 2020
11.7.5. Spain Per Capita Average Gastrointestinal Drugs Expenditure, 2012 - 2020
12. Eastern Europe Gastrointestinal Drugs Market
12.1.1. Eastern Europe Gastrointestinal Drugs Market Overview
12.1.2. Eastern Europe Gastrointestinal Drugs Historic Market, 2012 - 2016
12.1.3. Eastern Europe Gastrointestinal Drugs Forecast Market, 2016 - 2020
12.1.4 Eastern Europe Gastrointestinal Drugs Market, 2016, By Segment
Antacids
Antacids
Antiulcerants
Vitamin And Minerals
Antiobesity Drugs
Antiemetics And Antinauseants
Antidiarrhoeals
12.2. Eastern Europe Gastrointestinal Drugs Market: Country Analysis
12.3. Russia Gastrointestinal Drugs Market
12.3.1. Russia Gastrointestinal Drugs Historic Market, 2012 - 2016
12.3.2. Russia Gastrointestinal Drugs Forecast Market, 2016 - 2020
12.3.3. Russia Gastrointestinal Drugs Market, 2016, By Segment
Antacids
Antiulcerants
Vitamin And Minerals
Antiobesity Drugs
Antiemetics And Antinauseants
Antidiarrhoeals
12.3.4. Russia Gastrointestinal Drugs Percentage Of GDP, 2012 - 2020
12.3.5. Russia Per Capita Average Gastrointestinal Drugs Expenditure, 2012 - 2020
13. North America Gastrointestinal Drugs Market
13.1.1. North America Gastrointestinal Drugs Market Overview
13.1.2. North America Gastrointestinal Drugs Historic Market, 2012 - 2016
13.1.3. North America Gastrointestinal Drugs Forecast Market, 2016 - 2020
13.1.4. North America Gastrointestinal Drugs Market, 2016, By Segment
Antacids
Antiulcerants
Vitamin And Minerals
Antiobesity Drugs
Antiemetics And Antinauseants
Antidiarrhoeals
13.2. North America Gastrointestinal Drugs Market: Country Analysis
13.3. USA Gastrointestinal Drugs Market
13.3.1. USA Gastrointestinal Drugs Historic Market, 2012 - 2016
13.3.2. USA Gastrointestinal Drugs Forecast Market, 2016 - 2020
13.3.3 USA Gastrointestinal Drugs Market, 2016, By Segment
Antacids
Antiulcerants
Vitamin And Minerals
Antiobesity Drugs
Antiemetics And Antinauseants
Antidiarrhoeals
13.3.4. USA Gastrointestinal Drugs Percentage Of GDP, 2012 - 2020
13.3.5. USA Per Capita Average Gastrointestinal Drugs Expenditure, 2012 - 2020
14. South America Gastrointestinal Drugs Market
14.1.1. South America Gastrointestinal Drugs Market Overview
14.1.2. South America Gastrointestinal Drugs Historic Market, 2012 - 2016
14.1.3. South America Gastrointestinal Drugs Forecast Market, 2016 - 2020
14.1.4. South America Gastrointestinal Drugs Market, 2016, By Segment
Antacids
Antiulcerants
Vitamin And Minerals
Antiobesity Drugs
Antiemetics And Antinauseants
Antidiarrhoeals
14.2. South America Gastrointestinal Drugs Market: Country Analysis
14.3. Brazil Gastrointestinal Drugs Market
14.3.1. Brazil Gastrointestinal Drugs Historic Market, 2012 - 2016
14.3.2. Brazil Gastrointestinal Drugs Forecast Market, 2016 - 2020
14.3.3. Brazil Gastrointestinal Drugs Market, 2016, By Segment
Antacids
Antiulcerants
Vitamin And Minerals
Antiobesity Drugs
Antiemetics And Antinauseants
Antidiarrhoeals
14.3.4. Brazil Gastrointestinal Drugs Percentage Of GDP, 2012 - 2020
14.3.5. Brazil Per Capita Average Gastrointestinal Drugs Expenditure, 2012 - 2020
15. Middle East Gastrointestinal Drugs Market
15.1.1. Middle East Gastrointestinal Drugs Market Overview
15.1.2. Middle East Gastrointestinal Drugs Historic Market, 2012 - 2016
15.1.3. Middle East Gastrointestinal Drugs Forecast Market, 2016 - 2020
15.1.4. Middle East Gastrointestinal Drugs Market, 2016, By Segment
Antacids
Antiulcerants
Vitamin And Minerals
Antiobesity Drugs
Antiemetics And Antinauseants
Antidiarrhoeals
16. Africa Gastrointestinal Drugs Market
16.1.1. Africa Gastrointestinal Drugs Market Overview
16.1.1. Africa Gastrointestinal Drugs Market Overview
16.1.2. Africa Gastrointestinal Drugs Historic Market, 2012 - 2016
16.1.3. Africa Gastrointestinal Drugs Forecast Market, 2016 - 2020
16.1.4. Africa Gastrointestinal Drugs Market, 2016, By Segment
Antacids
Antiulcerants
Vitamin And Minerals
Antiobesity Drugs
Antiemetics And Antinauseants
Antidiarrhoeals
17. Gastrointestinal Drugs Market Competitive Landscape
17.1. Company Profiles
17.2. Abbvie
17.2.1. Overview
17.2.2. Products And Services
17.2.3. Strategy
17.2.4. Financial Performance
17.3. Johnson & Johnson
17.3.1. Overview
17.3.2. Products And Services
17.3.3. Strategy
17.3.4. Financial Performance
17.4. Takeda Pharmaceuticals
17.4.1. Overview
17.4.2. Products And Services
17.4.3. Strategy
17.4.4. Financial Performance
17.5. Allergan
17.5.1. Overview
17.5.2. Products And Services
17.5.3. Strategy
17.5.4. Financial Performance
17.6. Ucb
17.6.1. Overview
17.6.2. Products And Services
17.6.3. Strategy
17.6.4. Financial Performance
18. Key Mergers And Acquisitions In The Gastrointestinal Drugs Market
19. Market Background: Pharmaceutical Drugs Market
19.1.1. Pharmaceutical Drugs Market Characteristics
19.1.2. Pharmaceutical Drugs Market Historic Growth
19.1.2.1. Drivers Of The Market
19.1.2.2. Restraints Of The Market
19.1.3. Pharmaceutical Drugs Market Forecast Growth
19.1.3.1. Drivers Of The Market
19.1.3.2. Restraints Of The Market
19.1.4. Pharmaceutical Drugs Trends And Strategies
19.2. Pharmaceutical Drugs Market Regional And Country Analysis
19.2.1. Global Pharmaceutical Drugs Market, 2016, By Region
19.2.2. Global Pharmaceutical Drugs Market, 2012 - 2020, Historic And Forecast, By Region
19.2.3. Pharmaceutical Drugs Market, 2016, By Country
19.2.4. Pharmaceutical Drugs Market, 2012 - 2020, Historic And Forecast, By Country
19.2.5. Global Pharmaceutical Drugs Market, Growth And Market Share Comparison, By Segment
19.2.6. Global Pharmaceutical Drugs Market, Growth And Market Share Comparison, By Country And Segment
19.3. Global Pharmaceutical Drugs Market Comparison With Macro Economic Factors
19.3.1. Pharmaceutical Drugs Market Size, Percentage Of GDP, Global
19.3.2. Per Capita Average Pharmaceutical Drugs Expenditure, Global
19.4. Pharmaceutical Drugs Market Comparison With Macro Economic Factors Across Countries
19.4.1. Pharmaceutical Drugs Market Size, Percentage Of GDP, By Country
19.4.2. Per Capita Average Pharmaceutical Drugs Expenditure, By Country
19.5. Key Mergers And Acquisitions In The Pharmaceutical Drugs Market
20. Pharmaceuticals Industry Financial Margins
21. Appendix
21.1. Naics Definitions Of Industry Covered In This Report
21.2. Abbreviations
21.3. Currencies
21.4. Research Inquiries
21.5. The Business Research Company
21.6. Copyright And Disclaimer

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report